以患者为中心的居家体力活动项目在乳腺癌新辅助化疗期间维持生活质量:AURORA随机对照试验方案
AURORA试验为9周随机对照试验方案,拟在智利首都大区招募30例70岁以下接受新辅助化疗的乳腺癌女性,随机1:1分配至Aurora实验组或对照组,主要结局为生活质量,次要结局包括功能能力与生物学标志物,注册号NCT06449417。
要点
- AURORA为9周随机对照试验方案,计划纳入30例70岁以下接受新辅助化疗的乳腺癌女性。
- 参与者先接受标准化在线教育课后按1:1随机分配至Aurora实验组或对照组。
- 主要结局为生活质量,次要结局包括功能能力测试与生物学标志物。
核心结论
- 作者的概念假设是Aurora干预方案相比对照组对主要和次要结局产生积极影响,并期望Aurora项目在体力活动依从性、强度和时长上比标准照护产生更显著的效果。
研究设计与样本
- 本方案为9周随机对照试验,计划在智利首都大区招募30例70岁以下接受新辅助化疗的女性乳腺癌患者。
- 参与者先接受关于体力活动益处的标准化在线教育课,随后按1:1比例随机分配至9周Aurora实验方案或Aurora对照方案。
- 研究采用混合方法,通过基线和干预后测量评估多维治疗效果。
主要发现
- 主要结局为生活质量,通过问卷和患者感知评估,并对患者记录的日记和深入小组访谈进行主题分析以评估情感治疗效果。
- 次要结局包括功能能力测试以测量不良身体效应,以及通过脂质谱、炎症生物标志物和肿瘤进展评估的生物学标志物。
- Aurora实验方案提供含运动器材的品牌盒、设计日志本、水杯、运动传单和臂围测量软尺的实验套件。
- Aurora对照方案提供含空白笔记本、水杯和运动传单的品牌手提袋对照套件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the known benefits of physical activity for women with breast cancer (BC), adherence to recommended guidelines remains low, especially during neo-adjuvant chemotherapy. The Aurora intervention presents a multidimensional approach to improve physical activity adherence, considering the patient's emotional and physical needs and barriers to physical activity. This protocol aims to evaluate Aurora's effects compared to standard care in BC patients. METHODS: In this 9-week randomized controlled trial, 30 female BC patients under 70 years of age, undergoing neo-adjuvant chemotherapy in the Metropolitan Region of Chile, will be recruited. Participants will receive a standard online education class on the benefits of physical activity for BC patients, which includes general information on the importance of exercise during treatment, recommended physical activity guidelines, and tips for safely incorporating movement into daily routines. Afterward, participants will be randomly allocated in a 1:1 ratio to either the 9-week Aurora experimental program (Aurora experimental kit: branded box containing exercise equipment, designed logbook journal, hydration bottle, exercise leaflet, and arm volume measurement tape) or the Aurora control program (Aurora control kit: branded tote bag containing a blank notebook, hydration bottle, and exercise leaflet). The study will employ a mixed-methods approach to assess multidimensional treatment effects through baseline and post-intervention measurements. The primary outcome will be quality of life, which will be assessed using questionnaires and patient perceptions, with thematic analysis of patient-recorded journals and in-depth group interviews to evaluate emotional treatment effects. Secondary outcomes will include (1) functional capacity tests to measure adverse physical effects and (2) biological markers assessed through lipid profiling, inflammation biomarkers, and tumor progression. DISCUSSION: Our conceptual hypothesis is that the Aurora intervention program will positively impact primary and secondary outcomes compared to the control group. Integrating the behavior change COM-B model and a patient-centered design facilitates tailoring interventions to BC patients' multidimensional needs and barriers. Additionally, we expect the Aurora program to promote more significant effects than standard care on physical activity adherence, intensity, and time. TRIAL REGISTRATION: The study was registered at ClinicalTrials.gov, NCT06449417. Registered on May 28, 2024. Unique Protocol ID: 230126002. https://clinicaltrials.gov/study/NCT06449417 .
引用
- Montt-Blanchard D, Ramírez-Parada K, Montecinos V, et al. Home-based patient-centered physical activity program for quality of life preservation during neoadjuvant chemotherapy in breast cancer: the AURORA randomized controlled trial protocol. Trials. 2026. PMID: 41501916. doi:10.1186/s13063-025-09301-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。